MTM Collaborative Practice Agreements 3

Question 1

A pharmacist working under a CPA in a diabetes clinic wants to start insulin therapy for a newly diagnosed patient. The CPA covers 'glucose-lowering medication initiation.' What should the pharmacist verify first?

Accepted Answer

That the patient meets the inclusion criteria specified in the CPA

Answer

Before acting under a CPA, the pharmacist must confirm the patient meets the CPA's defined inclusion criteria.

Question 2

In which care setting have CPAs historically been LEAST utilized?

Accepted Answer

Community independent pharmacies

Answer

Community independent pharmacies have historically had the lowest CPA utilization, often due to lack of physician relationships and reimbursement barriers.

Question 3

When documenting a pharmacist intervention made under a CPA, which is the MOST important piece of information to record?

Accepted Answer

Clinical rationale for the action taken and the outcome

Answer

Clinical rationale and outcomes documentation demonstrates that the pharmacist acted within the CPA scope and supports continuity of care.

Question 4

A state pharmacy board is considering expanding CPA authority. Which argument BEST supports this expansion?

Accepted Answer

CPAs improve medication adherence, outcomes, and healthcare access

Answer

Evidence shows CPAs improve medication adherence, clinical outcomes, and access to care, especially in underserved areas.

Question 5

Which of the following would be OUTSIDE the scope of a standard CPA for a clinical pharmacist?

Accepted Answer

Diagnosing hypertension de novo without physician input

Answer

Diagnosis of a new condition is a physician function and is excluded from pharmacist scope even under a CPA.

(MTM) Medication Therapy Management Board Certification Practice Test

(MTM) Medication Therapy Management Board Certification Practice Test

MTM Collaborative Practice Agreements 3